CD4 and COVID-19: For RBD mRNA-LNP, it has also been demonstrated that a single immunization elicited potent CD4+ and CD8+ T cell responses in lungs in addition to spleens, indicating a potential contribution to immune protection against SARS-CoV-2 infection35.